Brief: Amniotics Q4 EBITDA Loss Narrows To SEK 12.4 Mln
Feb 17 (Reuters) - Amniotics AB (publ) AMNI.ST :
* REPORT FOR THE FOURTH QUARTER 2021
* Q4 OPERATING PROFIT (EBITDA): SEK -12.4 (-13.9) MILLION.
* Q4 TOTAL REVENUES: SEK 0 (0).
Source text for Eikon: ID:nMFN20NX3x
Further company coverage: AMNI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Amniotics AB (publ)
See all newsBrief: Swedish Companies Registration Office Authorises Magle Group, Amniotics Merger Plan
Brief: Amniotics H1 Net Revenue SEK 2.5 Million
Brief: Amniotics Gets Conditional Approval To Delist From Nasdaq First North Growth Market
Brief: Amniotics To Delist From Nasdaq First North Growth Market Upon Magle Group Merger Completion
Brief: Magle Chemoswed, Amniotics Adopt Merger Plan